Showing results (201-210 of 242) with videos related to
Sort By:
Pageof 25
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 25, 2013
Gastric reflux is an independent risk factor for laryngopharyngeal carcinomaScott M Langevin, Dominique S Michaud, Carmen J Marsit, et al.Proceedings of the National Academy of Sciences of the United States of America|July 20, 2018
Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcroMarvin H Gee, Leah V Sibener, Michael E Birnbaum, et al.Cell|December 22, 2015
Control of Synaptic Connectivity by a Network of Drosophila IgSF Cell Surface ProteinsRobert A Carrillo, Engin Özkan, Kaushiki P Menon, et al.Cytotherapy|June 7, 2025
Use of cellular FAD autofluorescence as a label-free cellular attribute for the production of chimeric antigen receptor T cellsKa-Wai Cheung, Faris Kairi, Denise Bei Lin Teo, et al.Cell Systems|April 11, 2025
Library-based single-cell analysis of CAR signaling reveals drivers of in vivo persistenceCaleb R Perez, Andrea Garmilla, Avlant Nilsson, et al.Biorxiv : the Preprint Server for Biology|May 15, 2024
Library-based single-cell analysis of CAR signaling reveals drivers of in vivo persistenceCaleb R Perez, Andrea Garmilla, Avlant Nilsson, et al.Nature Immunology|November 3, 2015
Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivityJarrett J Adams, Samanthi Narayanan, Michael E Birnbaum, et al.Proceedings of the National Academy of Sciences of the United States of America|November 26, 2014
Molecular architecture of the αβ T cell receptor-CD3 complexMichael E Birnbaum, Richard Berry, Yu-Shan Hsiao, et al.Elife|August 7, 2023
Decoupled neoantigen cross-presentation by dendritic cells limits anti-tumor immunity against tumors with heterogeneous neoantigen expressionKim Bich Nguyen, Malte Roerden, Christopher J Copeland, et al.Cancer Immunology Research|October 25, 2018
Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell-Effector ResponsesEleanor Clancy-Thompson, Christine A Devlin, Paul M Tyler, et al.Pageof 25